How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapy-Reference-Cited by-同舟云学术

How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapy

Published:2017-10-19 Issue:1 Volume:180 Page:24-32
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Rea Delphine¹^ORCID,Mahon François-Xavier²

Affiliation:

1. Service d'hématologie Adulte; Unité INSERM; UMR-1160 and France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC); Hôpital Saint-Louis; Paris France

2. Unicancer Center; Institut Bergonié and France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC); Bordeaux France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14973/fullpdf

Reference49 articles.

1. CML and tyrosine kinase inhibition: the hope becomes reality;Apperley;The Lancet Haematology,2015

2. European LeukemiaNet recommendations for the management of chronic myeloid leukemia;Baccarani;Blood,2013

3. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population;Bower;Journal of Clinical Oncology,2016

4. BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management;Branford;Blood,2012

5. Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response;Cervantes;Annals of Hematology,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety;Expert Opinion on Drug Safety;2024-06-17

2. Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel;Blood Advances;2021-11-24

3. Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools;Targeted Oncology;2021-10-18

4. Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 Leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways;International Journal of Molecular Sciences;2021-04-20

5. Handling challenging questions in the management of chronic myeloid leukemia: when is it safe to stop tyrosine kinase inhibitors?;Hematology;2020-12-04